Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 1c, Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Hims & Hers Health, Inc. Reports Record Fourth Quarter and Full Year 2022 Financial Results
February 27, 2023 4:15 PM ESTFull year 2022 revenue of $526.9 million, up 94% year-over-year
Q4 2022 record revenue of $167.2 million, up 97% year-over-year
Q4 2022 net loss of $10.9 million and achieves Adjusted EBITDA profitability of $3.9 million
Eclipses one million subscribers at year end, up 88% year-over-year
Provides Q1 and full year 2023 guidance, with full year 2023 revenue in the range of $735 million to $755 million and Adjusted EBITDA in the range of $20 million to $30 million
Introduces 2025 targets of at least $1.2 billion in revenue and $100 million in... More
